Unlocking Genomic Insights for Precision Medicine
We provide advanced Next-Generation Sequencing (NGS) services to support cancer profiling, hereditary disease assessment, reproductive genetics, and precision medicine. Our comprehensive portfolio includes liquid biopsy, solid tumor mutation analysis, lung and colorectal cancer panels, hereditary cancer gene panels (including BRCA1/BRCA2), NIPT, PGT-A, HRR and HRD testing, and single-gene mutation analysis.
We also offer Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), and Clinical Exome Sequencing (CES) to support the investigation of rare genetic disorders, inherited diseases, and complex clinical conditions.
Combining advanced genomic technology with quality-focused laboratory practices, we empower healthcare professionals with reliable genetic insights to support informed clinical decisions and personalized patient care.
Advanced Genomics. Actionable Insights. Better Patient Care.